Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/38023| Title: | Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction! | Authors: | VRANCKX, Pascal Valgimigli, Marco |
Issue Date: | 2022 | Publisher: | EUROPA EDITION | Source: | EuroIntervention, 18 (4) , p. E267 -E268 | Notes: | Vranckx, P (corresponding author), Jessa Ziekenhuis, Hartctr Hasselt, Stadsomvaart 11, B-3500 Hasselt, Belgium. Pascal.Vranckx@jessazh.be |
Keywords: | Anticoagulants;Drug Therapy, Combination;Fibrinolytic Agents;Humans;Platelet Aggregation Inhibitors;Atrial Fibrillation;Percutaneous Coronary Intervention | Document URI: | http://hdl.handle.net/1942/38023 | ISSN: | 1774-024X | e-ISSN: | 1969-6213 | DOI: | 10.4244/EIJ-E-22-00004 | ISI #: | 000840791900001 | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| The antithrombotic therapy.pdf Restricted Access | Peer-reviewed author version | 548.91 kB | Adobe PDF | View/Open Request a copy |
| Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction! - EuroIntervention.pdf Restricted Access | Published version | 244.61 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.